Multidisciplinary approach in management of patients with immune thrombocytopenia and ischemic heart disease

Immune thrombocytopenia in patients with concomitant cardiovascular disorders requiring antiplatelet and anticoagulant therapy can increase the risk of hemorrhages and arterial and venous thromboembolic complications. This situation necessitates special patient management. Multidisciplinary approach is important for patients requiring myocardial revascularization due to the necessity of administration of double or triple antiplatelet therapy.The article presents our experience in management of patients with immune thrombocytopenia and high functional class stable angina requiring coronary artery stent.